MARKET

ARKG

ARKG

ARK Genomic Revolution ETF
BATS
31.26
+0.68
+2.22%
After Hours: 31.47 +0.21 +0.67% 19:06 12/08 EST
OPEN
30.80
PREV CLOSE
30.58
HIGH
31.48
LOW
30.20
VOLUME
1.29M
TURNOVER
0
52 WEEK HIGH
65.85
52 WEEK LOW
26.38
TOTAL ASSET
2.11B
YTD YIELD
-51.77%
1D
5D
1M
3M
1Y
5Y
Cathie Wood Adds $7M Of This Clinical-Stage Biotech, Trims Stake In CVS-Target Signify Health
Benzinga · 1d ago
This Congressman Just Purchased 2 Stocks Which Consistently Increase Dividends
Benzinga · 11/28 15:40
Cathie Wood Increases Stake In 4 Stocks By Over 1,000% - Plus 4 New Holdings For Ark
Benzinga · 11/22 16:33
Cathie Wood Teams Up With This Investment Bank To Offer Ark Invest's ETFs In Canada
Benzinga · 11/19 19:48
Cathie Wood’s ARKK rises 10%+, putting it on track for its best trading day ever
Seekingalpha · 11/10 16:45
SARK, the anti-Cathie Wood ETF, has returned over 100% in its first year of trading
Seekingalpha · 11/07 17:42
On its 8th birthday, lifetime gains at Cathie Wood’s ARKK have fallen behind the S&P 500
Seekingalpha · 10/31 13:04
Cathie Wood’s ARKK closed at lowest level in five years
Seekingalpha · 10/17 12:22
More
Profile
Fund Name
ARK Genomic Revolution ETF
Inception Date
2014-10-31
Benchmark
NASDAQ Health Care GR EUR
Advisor Company
ARK Investment Management LLC
Custodian
Bank of New York Mellon
Manager
Catherine Wood